Endothelial function in the time of the giants

Journal of Cardiovascular Pharmacology

Volumn 52, Issue 5, 2008, Pages 385-392

  Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Aortic valve; Endothelium; Oxidative stress; Serotonin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEROTONIN; SUPEROXIDE DISMUTASE;

AORTA VALVE STENOSIS; ATHEROSCLEROSIS; CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; GENE TRANSFER; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; VASOCONSTRICTION; VASOMOTOR REFLEX; VASOSPASM; ANIMAL; CARDIOVASCULAR DISEASE; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; SEROTONIN; SUPEROXIDE DISMUTASE;

EID: 59449098842     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31818a403b     Document Type: Conference Paper

References (41)

1. Furchgott FR, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376.
2. Cohen R, Shepherd J, Vanhoutte P. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science. 1983;221: 173-174.
3. Vanhoutte PM, Houston DS. Platelets, endothelium, and vasospasm. Circulation. 1985;72:728-734.
4. Houston DS, Shepherd JT, Vanhoutte PM. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. J Clin Invest. 1986;78:539-544.
5. Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine: Mediation by a serotonergic mechanism. J Clin Invest. 1980; 66:306-313.
6. Heistad DD, Armstrong ML, Marcus ML, et al. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;54:711-718.
7. Hayreh SS, Piegors DJ, Heistad DD. Serotonin-induced constriction in ocular arteries in atherosclerotic monkeys: Implications for ischemic disorders of the retina and optic nerve head. Arch Ophthalmol. 1997;115: 220-228.
8. Williams JK, Baumbach GL Armstrong ML, Heistad D. Hypothesis: vasoconstriction contributes to amaurosis fugax. J Cereb Blood Flow Metab. 1989;9:111-116.
9. Freiman PC, Mitchell GG, Heistad DD, et al. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res. 1986;58:783-789.
10. Kaul S, Heistad DD, Mügge A, et al. Vascular responses to platelet activation in normal and atherosclerotic primates in vivo. Arterioscler Thromb. 1991;11:1745-1751.
11. Kaul S, Padgett RC, Waack BJ, et al. Effect of atherosclerosis on responses of the perfused rabbit carotid artery to human platelets. Arterioscleros Thromb. 1992;12:1206-1213.
12. Kaul S, Waack BJ, Padgett RC, et al. Altered vascular responses to platelets from hypercholesterolemic humans. Circ Res. 1993;72:737-743.
13. Willerson J, Hillis M, Winniford M, Buja L. Speculation regarding mechanisms responsible for acute ischemic heart disease syndrome. J Am Coll Cardiol. 1986;8:245-250.
14. Mügge A, Lopez JAG, Piegors DJ, et al. Acetylcholine-induced vasodilation in the rabbit hindlimb is not inhibited by analogues of L-arginine. Am J Physiol Heart Circ Physiol. 1991;29:H242-H247.
15. Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26: 1215-1225.
16. Heistad DD, Armstrong ML. Sick vessel syndrome: Can atherosclerotic arteries recover? Circulation. 1994;89:2447-2450.
17. Armstrong ML, Warner E, Conner W. Regression of coronary atheromatosis in rhesus monkeys. Circ Res. 1970;27:59-67.
18. Harrison DG, Armstrong ML, Freiman PC, et al. Restoration of endothelium dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 1987;80:1808-1811.
19. Armstrong ML, Heistad DD, Marcus ML, et al. Hemodynamic sequelae of regression of experimental atherosclerosis. J Clin Invest. 1983;71: 104-113.
20. Heistad DD, Mark AL, Marcus ML, et al. Dietary treatment of atherosclerosis abolishes hyperresponsiveness to serotonin: Implications for vasospasm. Circ Res. 1987;61:346-351.
21. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet. 1993;341:1496-1500.
22. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
23. Levine GN, Keaney JFJ, Vita JA. Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms. N Engl J Med. 1995; 332:512-521.
24. Benzuly KH, Padgett RC, Kaul S, et al. Functional improvement precedes structural regression of atherosclerosis. Circulation. 1994;89: 1810-1818.
25. Hathaway C, Heistad DD, Piegors DJ, Miller FM. Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ Res. 2002;90:277-283.
26. Butcher JT, Penrod AM, Garćia AJ, et al. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004;24:1429-1434.
27. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111:3316-3326.
28. Lieu HD, Withycombe SK, Walker Q, et al. Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation. 2003; 107:1315-1321.
29. Weiss RM, Ohashi M, Miller JD, et al. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006;114:2065-2069.
30. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Peña-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Amer Coll Cardiol. 2008, in press.
31. Liberman M, Bassi E, Martinatti Mk, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28:463-470.
32. Fukai T, Galis ZS, Meng XP, et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest. 1998;101:2101-2111.
33. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352: 2389-2397.
34. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554-561.
35. Miller JD, Berry CJ, Serrano KM, et al. Effects of normalizing hyperlipidemia on oxidative stress and disease progression in a mouse model of aortic valve stenosis [abstract]. Circulation. 2007;116:Ii-52.
36. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: A regulator of nitric oxide bioavailability. Lab Invest. 1996;75:617-636.
37. Chu Y, Iida S, Lund DD, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: Role of heparin binding domain. Circ Res. 2003;92:461-468.
38. Juul K, Tybjaerg-Hansen A, Marklund S, et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation. 2004;109:59-65.
39. Chu Y, Alwahdani A, Iida S, et al. Vascular effects of human extracellular superoxide dismutase R213G variant. Circulation. 2005;112:1047-1053.
40. Iida S, Chu Y, Weiss RM, et al. Vascular Effects of a common gene variant of extracellular superoxide dismutase in heart failure. Am J Physiol Heart. 2006;291:H914-920.
41. Lund DD, Chu Y, Brooks RM, et al. Effects of a common human gene variant of Ecsod on endothelial function after endotoxin in mice. J Physiol (London). 2007;584:583-590.